Weinhoff Gregory M
Chief Business Officer
Weinhoff Gregory M has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jun 24, 2026.
On the most recent filing, Weinhoff Gregory M is listed as Chief Business Officer at Centessa Pharmaceuticals plc. Inside the rolling window, Weinhoff Gregory M reported no open-market purchases and 2 open-market sales totaling $2.6M in CNTA. The largest disclosed transaction in the window is a sale of 73,196 CNTA shares on Mar 13, 2026, worth $1.9M.
Companies traded
Other insiders at CNTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Weinhoff Gregory M made?
Weinhoff Gregory M has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Weinhoff Gregory M trade?
Weinhoff Gregory M has filed SEC Form 4 disclosures for 1 company, including CNTA.
When was Weinhoff Gregory M's most recent SEC Form 4 filing?
Weinhoff Gregory M's most recent SEC Form 4 filing on Tracefour is dated Jun 24, 2026.
What is Weinhoff Gregory M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Weinhoff Gregory M is listed as Chief Business Officer.
What is Weinhoff Gregory M's total buy and sell value in the current window?
Inside the rolling retention window, Weinhoff Gregory M bought $0 and sold $2.6M based on SEC Form 4 filings.
What was Weinhoff Gregory M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 73,196 CNTA shares on 2026-03-13, worth $1.9M, per SEC Form 4 filings.